Company
Last deal
$42.2M
Local Amount - JPY 6.B
Amount
Series A
Stage
17.07.2024
Date
1
all rounds
$42.2M
Total amount
General
About Company
Renalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications.
founded date
2023
Company Type
For Profit
Last funding type
Series A
IPO status
Private
Contacts
location
Website URL